O. Wong, Tung-hao Chang, C. Pi, Lien-Yen Wang, Mucang Liu, Mu-Kuan Chen, S. Kuo, Wenlin Huang
{"title":"放射治疗的PET-CT成像:从临床生物学靶标定义到转化研究","authors":"O. Wong, Tung-hao Chang, C. Pi, Lien-Yen Wang, Mucang Liu, Mu-Kuan Chen, S. Kuo, Wenlin Huang","doi":"10.6501/CJM.1202.001","DOIUrl":null,"url":null,"abstract":"Medical modalities for molecular imaging such as F-18 fluorodeoxyglucose positron emission tomography (FDG-PET), has become an important surrogate biomarker that reflects cellular glucose metabolism. It has been applied to the staging, re-staging, therapeutic monitoring and follow-up of patients with various tumors. Phenotypic information is being used to increase the accuracy of radiation treatment planning, by fusing CT planning images, which has resulted in better tumor control and fewer treatment related toxicities. Applications of PET-CT using biotracers other than FDG in clinical radiotherapy research and in translational research for radiotherapy are intensively investigated which may offer additional parameters in therapeutic targeting.","PeriodicalId":404480,"journal":{"name":"The Changhua Journal of Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PET-CT Imaging for Radiotherapy: From Clinical Biologic Target Definition to Translational Research\",\"authors\":\"O. Wong, Tung-hao Chang, C. Pi, Lien-Yen Wang, Mucang Liu, Mu-Kuan Chen, S. Kuo, Wenlin Huang\",\"doi\":\"10.6501/CJM.1202.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medical modalities for molecular imaging such as F-18 fluorodeoxyglucose positron emission tomography (FDG-PET), has become an important surrogate biomarker that reflects cellular glucose metabolism. It has been applied to the staging, re-staging, therapeutic monitoring and follow-up of patients with various tumors. Phenotypic information is being used to increase the accuracy of radiation treatment planning, by fusing CT planning images, which has resulted in better tumor control and fewer treatment related toxicities. Applications of PET-CT using biotracers other than FDG in clinical radiotherapy research and in translational research for radiotherapy are intensively investigated which may offer additional parameters in therapeutic targeting.\",\"PeriodicalId\":404480,\"journal\":{\"name\":\"The Changhua Journal of Medicine\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Changhua Journal of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.6501/CJM.1202.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Changhua Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6501/CJM.1202.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PET-CT Imaging for Radiotherapy: From Clinical Biologic Target Definition to Translational Research
Medical modalities for molecular imaging such as F-18 fluorodeoxyglucose positron emission tomography (FDG-PET), has become an important surrogate biomarker that reflects cellular glucose metabolism. It has been applied to the staging, re-staging, therapeutic monitoring and follow-up of patients with various tumors. Phenotypic information is being used to increase the accuracy of radiation treatment planning, by fusing CT planning images, which has resulted in better tumor control and fewer treatment related toxicities. Applications of PET-CT using biotracers other than FDG in clinical radiotherapy research and in translational research for radiotherapy are intensively investigated which may offer additional parameters in therapeutic targeting.